Exercise boosts recovery in stem cell patients, small trial suggests
NCT ID NCT07458854
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a supervised 8-week exercise program (strength, endurance, and flexibility) could help patients recover after an autologous stem cell transplant. Fifteen adults with blood cancers were randomly assigned to exercise or usual care. The researchers measured handgrip, back, and leg strength at several time points. The goal was to see if exercise could ease the physical decline often seen during transplant.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- structured exercise program (strength, endurance, flexibility)
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help patients regain strength and mobility faster after a stem cell transplant.
- What could go wrong
- This is a very small, early study with only 15 participants. The results may not apply to all patients, and the exercise program may be too demanding for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Oct 2014
- Finished
-
Sep 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years, \<65 years * Able to exercise at time of enrolment. * no methastasis Exclusion Criteria:- Unable to communicate or read in Turkish, * Contraindications to 3 T MRI (e.g., pacemaker or implanted metallic device). * co-morbid cardiac disease * painful joint
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autologous hematopoietic stem cell transplantation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erciyes University Faculty of Sport Science
Kayseri, Kayseri, 38039, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can regional data improve bone marrow transplant results for blood cancers?
- Could a frailty score predict which older cancer patients survive intensive care?
- Why COVID-19 hits blood cancer patients harder: scientists map the immune clues
- Softer chemo before stem cell transplant aims to cure blood cancers in frail children
- Can a new drug stop the Body's attack after stem cell transplants?
- Wearable patches could spot heart danger hiding in cancer treatment